Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

A. De Remigis; T.D. de Gruijl; J.N. Uram; S.C. Tzou; S. Iwama; M.V. Talor; T.D. Armstrong; S.J.A.M. Santegoets; S.F. Slovin; L. Zheng; D.A. Laheru; E.M. Jaffee; W.R. Gerritsen; A.J.M. van den Eertwegh; D.T. Le; P. Caturegli

doi:10.1002/ijc.28973

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

A. De Remigis
, T.D. de Gruijl
, J.N. Uram
, S.C. Tzou
, S. Iwama
, M.V. Talor
, T.D. Armstrong
, S.J.A.M. Santegoets
, S.F. Slovin
, L. Zheng
, D.A. Laheru
, E.M. Jaffee
, W.R. Gerritsen
, A.J.M. van den Eertwegh
, D.T. Le
, P. Caturegli

Research output: Contribution to journal › Article › Academic › peer-review

22 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	127-137
Journal	International Journal of Cancer
Volume	136
Issue number	1
DOIs	https://doi.org/10.1002/ijc.28973
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/ijc.28973

Development-of-thyroglobulin-antibodies-after-gvax-immunotherapy-is-associated-with-prolonged-survival.pdfFinal published version, 559 KBLicence: Taverne

Cite this

De Remigis, A., de Gruijl, T. D., Uram, J. N., Tzou, S. C., Iwama, S., Talor, M. V., Armstrong, T. D., Santegoets, S. J. A. M., Slovin, S. F., Zheng, L., Laheru, D. A., Jaffee, E. M., Gerritsen, W. R., van den Eertwegh, A. J. M., Le, D. T., & Caturegli, P. (2015). Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival. International Journal of Cancer, 136(1), 127-137. https://doi.org/10.1002/ijc.28973

@article{a4789f3752ac45569223966b81ca6654,

title = "Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival",

author = "\{De Remigis\}, A. and \{de Gruijl\}, T.D. and J.N. Uram and S.C. Tzou and S. Iwama and M.V. Talor and T.D. Armstrong and S.J.A.M. Santegoets and S.F. Slovin and L. Zheng and D.A. Laheru and E.M. Jaffee and W.R. Gerritsen and \{van den Eertwegh\}, A.J.M. and D.T. Le and P. Caturegli",

year = "2015",

doi = "10.1002/ijc.28973",

language = "Undefined/Unknown",

volume = "136",

pages = "127--137",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

number = "1",

}

De Remigis, A, de Gruijl, TD, Uram, JN, Tzou, SC, Iwama, S, Talor, MV, Armstrong, TD, Santegoets, SJAM, Slovin, SF, Zheng, L, Laheru, DA, Jaffee, EM, Gerritsen, WR, van den Eertwegh, AJM, Le, DT & Caturegli, P 2015, 'Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival', International Journal of Cancer, vol. 136, no. 1, pp. 127-137. https://doi.org/10.1002/ijc.28973

TY - JOUR

T1 - Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

AU - De Remigis, A.

AU - de Gruijl, T.D.

AU - Uram, J.N.

AU - Tzou, S.C.

AU - Iwama, S.

AU - Talor, M.V.

AU - Armstrong, T.D.

AU - Santegoets, S.J.A.M.

AU - Slovin, S.F.

AU - Zheng, L.

AU - Laheru, D.A.

AU - Jaffee, E.M.

AU - Gerritsen, W.R.

AU - van den Eertwegh, A.J.M.

AU - Le, D.T.

AU - Caturegli, P.

PY - 2015

Y1 - 2015

U2 - 10.1002/ijc.28973

DO - 10.1002/ijc.28973

M3 - Article

C2 - 24832153

SN - 0020-7136

VL - 136

SP - 127

EP - 137

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 1

ER -